Metastatic renal cell cancer: Major response to oxaliplatin, 5-fluorouracil, L-folinic acid (FOL-FOX) combination

被引：0
|
作者：
Chauffert, B [1 ]
Bonnotte, B [1 ]
Chvetzoff, G [1 ]
Flesch, M [1 ]
机构：
[1] CHU Dijon, Serv Med Interne Immunol Clin & Oncol, F-21034 Dijon, France
来源：
PRESSE MEDICALE | 1998年 / 27卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：859 / 859
页数：1
相关论文
共 50 条
  • [31] Does polychemotherapy with 5-fluorouracil, methotrexate, and L-folinic acid influence the selenium, zinc, and copper serum levels in cancer of digestive tract?
    Iodice, P
    Federico, A
    Federico, P
    Del Rio, A
    Mellone, MC
    Federico, P
    Catalano, G
    JOURNAL OF TRACE ELEMENTS IN EXPERIMENTAL MEDICINE, 2001, 14 (01): : 73 - 79
  • [32] Comparison of a 48-hour infusion of 5-fluorouracil without folinic acid with 24-hour folinic acid/5-fluorouracil in patients with metastatic colorectal cancer refractory to bolus folinic acid/5-fluorouracil - A prospective cohort study
    Moehler, M
    Gutzler, F
    Steinmann, S
    Boehme, M
    Raeth, U
    Stremmel, W
    Galle, PR
    Rudi, J
    CHEMOTHERAPY, 2003, 49 (1-2) : 85 - 89
  • [33] Oxaliplatin with high-dose folinic acid and 5-fluorouracil 48 H infusion in pretreated metastatic colorectal cancer (CRC)
    deGramont, A
    Vignoud, J
    Tournigand, C
    Louvet, C
    Varette, C
    Raymond, E
    Krulik, M
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 716 - 716
  • [34] Identification of predictive markers of response to 5-Fluorouracil and oxaliplatin in metastatic colorectal cancer
    Allen, Wendy L.
    Boyer, John
    Coyle, Vicky
    McCulla, Andrea
    McLean, Estelle G.
    Longley, Daniel B.
    Johnston, Patrick G.
    CANCER RESEARCH, 2006, 66 (08)
  • [35] Oxaliplatin in combination with 5-fluorouracil/leucovorin or capecitabine in elderly patients with metastatic colorectal cancer
    Arkenau, Hendrik-Tobias
    Graeven, Ullrich
    Kubicka, Stephan
    Grothey, Axel
    Englisch-Fritz, Christina
    Kretzschmar, Albrecht
    Greil, Richard
    Freier, Werner
    Seufferlein, Thomas
    Hinke, Axel
    Schmoll, Hans-Joachim
    Schmiegel, Wolff
    Porschen, Rainer
    CLINICAL COLORECTAL CANCER, 2008, 7 (01) : 60 - 64
  • [36] TREATMENT OF ADVANCED COLORECTAL-CANCER WITH FOLINIC ACID AND 5-FLUOROURACIL IN COMBINATION WITH CISPLATINUM
    SAGASTER, P
    ESSL, R
    TEICH, G
    FRITZ, E
    WASILEWSKI, M
    UMEK, H
    DUNSER, E
    MASCHER, H
    MICKSCHE, M
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (09) : 1250 - 1254
  • [37] THE ROLE OF FOLINIC ACID IN COMBINATION WITH 5-FLUOROURACIL IN THE TREATMENT OF ADVANCED COLORECTAL-CANCER
    WILKE, H
    HARSTRICK, A
    SEEBER, S
    ONKOLOGIE, 1995, 18 (01): : 65 - 67
  • [38] Phase I study of ursodeoxycholic acid in combination with 5-fluorouracil, leucovorin, oxaliplatin, and bevacizumab for metastatic colorectal cancer
    Lai, Lily L.
    Chiu, Ken
    Lim, Dean
    Chao, Joseph
    Frankel, Paul Henry
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [39] Weekly oxaliplatin, high-dose folinic acid and 24h-5-fluorouracil (FUFOX) as salvage therapy in metastatic colorectal cancer patients pretreated with irinotecan and folinic acid/5-fluorouracil regimens
    Moehler, M
    Hoffmann, T
    Hildner, K
    Siebler, J
    Galle, PR
    Heike, M
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2002, 40 (12): : 957 - 964
  • [40] Clinical and economic benefits of irinotecan in combination with 5-fluorouracil and folinic acid as first line treatment of metastatic colorectal cancer
    Cunningham, D
    Falk, S
    Jackson, D
    BRITISH JOURNAL OF CANCER, 2002, 86 (11) : 1677 - 1683
12345